Stuart Harlin, MD
Vascular Surgery · Katy, TXNPI 1568435618
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (53.9%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 34 manufacturers reported payments, led by Endologix LLC at 50.5% of the total. Reporting peaked in 2021 at $11,236 and has fallen 78.9% since, to $2,366 in 2025.
Across 261 payments — averaging $154.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Endologix LLC$20K
- Inari Medical, Inc.$10K
- Bard Peripheral Vascular, Inc.$3K
- Silk Road Medical, Inc.$2K
- Abbott$1K
- W. L. Gore & Associates, Inc.$837
- plus $4K from 28 others
Across 60 payments — averaging $1001.82 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$22K
- Inari Medical, Inc.$17K
- Merit Medical Systems Inc$13K
- Biocompatibles, Inc.$8K
What the payments were for
- Consulting fees$21,70054%
- Speaking & faculty fees$5501%
- Travel & lodging$4,35311%
- Food & beverage$13,65834%
- Education$40%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Endologix LLC | 47 | $20,348 |
| Inari Medical, Inc. | 42 | $9,759 |
| Bard Peripheral Vascular, Inc. | 57 | $2,671 |
| Silk Road Medical, Inc. | 11 | $1,943 |
| Abbott | 3 | $1,125 |
| W. L. Gore & Associates, Inc. | 9 | $837 |
| Boston Scientific | 15 | $577 |
| Medtronic(2 entities) | 10 | $522 |
| Veryan Medical Incorporated | 6 | $381 |
| Angiodynamics, Inc. | 6 | $327 |
| Cook Medical LLC | 7 | $272 |
| Bolton Medical Inc | 8 | $220 |
| Philips North America LLC | 3 | $207 |
| Surmodics, Inc. | 2 | $123 |
| Mercator Medsystems, Inc. | 1 | $109 |
| Johnson & Johnson | 4 | $99 |
| Cardiovascular Systems Inc. | 2 | $83 |
| Acera Surgical, Inc. | 2 | $73 |
| Medline Industries LP | 2 | $69 |
| Shockwave Medical, Inc | 1 | $69 |
| Cvrx, Inc. | 1 | $68 |
| Smith+Nephew | 4 | $64 |
| Tactile Systems Technology Inc | 4 | $56 |
| Imperative Care, Inc | 1 | $45 |
| Artivion, Inc. | 1 | $34 |
| EKOS Corporation | 2 | $33 |
| Thrombolex, Inc. | 1 | $30 |
| Venclose Inc. | 3 | $27 |
| Cardinal Health 200 LLC | 1 | $20 |
| Cagent Vascular Inc | 1 | $19 |
| Biocompatibles, Inc. | 1 | $16 |
| Cashflow Solutions, LLC | 1 | $15 |
| KCI USA, Inc. | 1 | $13 |
| Acell, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AFX2 Bifurcated Endograft System$14,785
- CT THROMBECTOMY SYSTEM KIT$11,620
- FLOWTRIEVER CATHETER, S$6,305
- Torus Stent Graft System$2,055
- ENROUTE Transcarotid Neuroprotection System$1,858
- ENDOCROSS Device$1,841
- Ovation iX Iliac Stent Graft$1,535
- ENROUTE Transcarotid Stent System$1,180
- ENHANCE Transcarotid Peripheral Access Kit$1,180
- ENROUTE 0.014 Guidewire$1,180
- Alto Abdominal Stent Graft System$1,116
- LUTONIX$1,050
- ENROUTE Transcarotid Stent$533
- Ovation$470
- AFX$330
- GORE VIABAHN VBX Balloon Expandable Endo$196
- GORE TAG Thoracic Branch Endoprosthesis$184
- ENDURANT IIS$173
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$146
- WATCHMAN Access System$133
How this compares
$40,265 in reported general payments places this provider in the 85th percentile of 347 vascular surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 100 | $75,947 |
| EliquisApixaban | 68 | $73,893 |
| Cilostazol | 325 | $5,092 |
| Pentoxifylline | 47 | $1,428 |
| ClopidogrelClopidogrel Bisulfate | 54 | $443 |
| Rosuvastatin Calcium | 11 | $293 |
| Atorvastatin Calcium | 20 | $262 |
| Ropinirole Hcl | 22 | $232 |
| Gabapentin | 26 | $204 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 36 | $195 |
| Meloxicam | 25 | $76 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $99 | $75,947100 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 347 vascular surgery providers in Texas.
Other vascular surgery in Katy
- Gregory PearlDallas$2.3M
- Mazin FotehAustin$1.6M
- Alan LumsdenHouston$742K
- Stephen HohmannDallas$499K
- Michael SiahDallas$392K
- Gustavo OderichHouston$319K
- Jean BismuthHouston$243K
- Carlos TimaranDallas$231K
- Dennis GableDallas$211K
- Thomas LohShenandoah$201K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.